Laura Lovett
The company will use the new funding to grow its US team and scale its commercial operations.
The Cedars-Sinai accelorator alumnus plans to use the money to grow its workforce and launch new engagement functionality.
As part of the deal Tabula Rasa will acquire the DoseMeRx platform, which gives clinicians information about how a patient will metabolize and absorb certain medications.
ResMed is expected to close the $225M deal to purchase the smart inhaler company by March 2019.
The health startups use AI to tackle a range of problems including malaria, addiction and diabetes.
The system would also include a smart medicine cabinet that could dispense more than 100 medications.
The study also found that comprehensive parity state mandates and the lack of psychiatrists were factors in telemedicine usage.
nOCD will now have a section on its homepage devoted to educating people about ketamine and connecting them to resources.
The platform will now let users share health records with pharma companies, health systems and insurers for remuneration.
The latest funding is expected to help the company grow its omnichannel approach to subscription growth, as well as for advertising and marketing.